Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice about NIH website updates and terminology appears above the ClinicalTrials.gov error page.
    Difference
    1%
    Check dated 2026-10-21T20:56:22.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T20:53:44.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T21:38:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study details, indicating that access to the record is blocked. This prevents viewing the trial information for this entry.
    Difference
    18%
    Check dated 2026-09-23T20:50:43.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows an updated release revision v3.7.0, replacing the prior v3.6.6. This signals a backend or UI update to the ClinicalTrials.gov entry without any changes to the study details.
    Difference
    0.1%
    Check dated 2026-09-16T21:58:04.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a new version of the page rendering used for the study record.
    Difference
    0.1%
    Check dated 2026-09-02T19:32:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.